Kato Rans retweeted
Elective para-aortic RT + 24 months ADT shows promising results in pN1 prostate cancer! In the PART trial (n=96), 5y clinical RFS reached 91% in the adjuvant setting vs 63% salvage (p=0.029) with acceptable toxicity. Early intervention matters. #ESTRO2025 #RadOnc #ProstateCancer
This Tuesday, I had the honor of successfully defending my PhD at the @KU_Leuven titled: "ππ‘π ππ¦ππ«π π’π§π ππ¨π₯π π¨π ππππ’π¨ππ‘ππ«ππ©π² π’π§ ππ’π π‘-ππ’π¬π€ ππ§π ππ₯π’π π¨π¦ππππ¬ππππ’π ππ«π¨π¬ππππ πππ§πππ«."
I am immensely grateful to my promoter Prof. Dr. @GertMeerleer and co-promoter Prof. Dr. @joniau for their guidance and support throughout this journey.
A heartfelt thank you to my jury members Dr. @alison_tree, Dr. @AmeyeFilip, Prof. Dr. @MaartenAlbersen, and Prof. Dr. Herlinde Dumez for their insightful feedback and constructive discussions. A special thanks to Prof. Dr. @heinvanpoppel and Prof. Dr. An Coosemans for your presence and support.
I also want to express my gratitude to the @Stkstichting and Rising Tide Foundation for Clinical Cancer Research for their financial support, which made this research possible.
Lastly, thank you to everyone who contributed to these projects, and to all the patients who placed their trust in our team!
Kato Rans retweeted
Phase 3 MEDCARE in M+CRPC is up and running! And it is running well! If interested: let us know. @KatoRans @joniau @karolien_goffin @BarbaraJereczek @CVulsteke #SBRT #SABR #ProstateCancer #hope
Kato Rans retweeted
π Experience the latest of urology at #ScientificSummits 2024!
Join us in πLeuven on May 24-25 for groundbreaking discussions on urothelial, prostate, and kidney cancer.
Register now! ππscientificsummits.eu/confereβ¦
Proud to present the final results of the MEDCARE phase II study published in @EurUrolOncol!
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer! β‘οΈ
@GertMeerleer @joniau @karolien_goffin @CharlienBerghen @Haustermans
authors.elsevier.com/c/1i~Pqβ¦
Honoured to present the Radiation Oncologistβs Perspective regarding the treatment of Prostate Cancer at #EAU24
#ProstateCancer
@GertMeerleer @joniau
Kato Rans retweeted
Oligometastatic Recurrent Prostate Cancer: Whether To Intensify Treatm... sciencedirect.com/science/arβ¦
Kato Rans retweeted
π BeGUS Post-ASCO GU Virtual Symposium 2024!
Dive into the latest on prostate, urothelial, & renal cancers!
π
March 25-26 | π₯οΈ Zoom | π Interactive Sessions & Panels
π Reserve your spot now: medcc.be/registration-begus-β¦
#BeGUS2024 #Urology #CancerResearch #VirtualCongress
Kato Rans retweeted
Happy and grateful to present our results of phase 2 MEDCARE trial in oligoprogressive metastatic castration-refractory prostate cancer @ASTRO23 SBRT postpones need for new systemic treatment with 1.5 years! More to follow. @KatoRans @joniau @karolien_goffin @Mat_Guc
Kato Rans retweeted
Ready for Scientific Summits. Top content in top location. #scisu @joniau @KarelDecaestec1 @KatoRans @ClaessensMarc @GevaertThomas @adamsthomas @CVulsteke
Proud to present the protocol of the SPARKLE Trial published in @BioMedCentral
Oligorecurrent prostate cancer: adding systemic treatment to metastasis-directed therapy: key to long-lasting event-free survival? π
@GertMeerleer @CharlienBerghen @joniau
bmccancer.biomedcentral.com/β¦
@AmeyeFilip @OlivierDeHertogh @JuliedenHartog
@CedericDraulans @HerlindeDumez @benediktengels2
@KarolienGoffin @NickLiefhooghe @kennethpoels @CarlSalembier @KoenSlabbaert @HansVandendriessche @ben_vanneste
142
Kato Rans retweeted
Current Issue: Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer
buff.ly/3Poku2c
@GertMeerleer @KatoRans @joniau @CharlienBerghen
#prostatecancer #urology #oncology #MedTwitter
Kato Rans retweeted
AddThis | Home
A plea for metastasis-directed therapy in low-volume castration-refractory prostate cancer. @joniau @KatoRans @CharlienBerghen @AlbertoBossial #prostatecancer #SBRT #MEDCARE
authors.elsevier.com/a/1f9DSβ¦
Looking Forward to the Scientific Summits!
Coming up this weekend online&live @ Ostend Thermae Palace π’Scientific Summits π’ top science-food-networking #urology #oncology #radiotherapy @GertMeerleer @joniau @MaartenAlbersen @_ShankarSiva @NoraSundahl @CharlesPraet @CarlSalembier @AlbertoBossial scientificsummits.eu/confereβ¦
4
Kato Rans retweeted
Join the discussion on postoperative radiation therapy in prostate cancer #case @GertMeerleer @joniau @KatoRans what would you advise to your patient?
AddThis | Home authors.elsevier.com/a/1f3K~β¦
π’SPARKLE trial is officially open π’
Metastasis-Directed Therapy for Oligorecurrent PCa
Open-label ph 3 trial (n=873)
πArm A: MDT
πArm B: MDT + 1m ADT
πArm C: MDT + 6m ADT + Enza
#prostatecancer #radonc
@GertMeerleer @CharlienBerghen @joniau
clinicaltrials.gov/ct2/show/β¦
















